Fierce Pharma Biopharma News & Insights
WEBFierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Health & Pharma News | Latest Healthcare Stories | Reuters
WEB5 days ago · Find latest healthcare news from every corner of the globe at Reuters.com, your online source for breaking international news coverage.
Pharmaceuticals sector - Financial Times
WEBSep 26, 2024 · Comprehensive coverage of the pharmaceuticals industry. The latest news and developments from the world's leading drug companies, including Pfizer, Johnson & Johnson, AstraZeneca and more.
Pharma Industry - Latest News, Investigations and Analysis
WEB5 days ago · The latest news on health and wellness, including the healthcare industry, pharmaceuticals and more.
Pharmaceuticals News - ScienceDaily
WEBOct 1, 2024 · Research news on the pharmaceutical industry including new drugs and interventions.
Fierce Biotech News & Reports
WEB6 days ago · Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of...
Biotech and Pharma Industry News | BioPharma Dive
WEBBioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
Endpoints News – Biotech, drug, pharma and health news for …
WEBBiotech, drug, pharma and health news for business and professional readers.
News | Timely industry updates for pharma and biotech leaders
WEB3 days ago · pharmaphorum’s news coverage updates daily with the latest pharma and biotech stories, from funding and M&A to regulatory approvals and policy shifts.
Fresh from the biotech pipeline: record-breaking FDA approvals
WEBFeb 26, 2024 · Amgen’s tarlatamab could become the first delta-like ligand 3 (DLL3)-targeting bispecific T cell engager for small-cell lung cancer while Jazz Pharmaceuticals’ dual HER2 blocker zanidatamab ...